Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicenter study
Corresponding Author
Joan Ceravalls
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Correspondence
Joan Ceravalls, Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Viladomat Street, 288, E-08029 Barcelona, Spain.
Email: [email protected]
Search for more papers by this authorRicardo Ruiz-Villaverde
Department of Dermatology, University Hospital San Cecilio, Instituto Biosanitario de Granada, Ibs, Granada, Spain
Search for more papers by this authorSusana Armesto
Department of Dermatology, Marqués de Valdecilla University Hospital, Santander, Spain
Search for more papers by this authorJosep Manel Fernández-Armenteros
Department of Dermatology, Hospital de Viladecans, Barcelona, Spain
Department of Dermatology, Hospital Universitari Arnau de Vilanova, Lleida, Spain
Search for more papers by this authorJosep Riera-Monroig
Department of Dermatology, Hospital Clínic de Barcelona, Barcelona, Spain
Search for more papers by this authorTamara Gracia-Cazaña
Department of Dermatology, Hospital Miguel Servet, Zaragoza, Spain
Search for more papers by this authorMònica Quintana-Codina
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Search for more papers by this authorMaribel Iglesias-Sancho
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Search for more papers by this authorMontserrat Salleras
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Search for more papers by this authorAdrián Imbernón Moya
Department of Dermatology, Hospital Universitario Severo Ochoa, Madrid, Spain
Search for more papers by this authorFrancisco Javier Melgosa Ramos
Department of Dermatology, Hospital Lluís Alcanyís de Xàtiva, Xàtiva, Spain
Search for more papers by this authorMarta Ferran
Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
Search for more papers by this authorCorresponding Author
Joan Ceravalls
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Correspondence
Joan Ceravalls, Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Viladomat Street, 288, E-08029 Barcelona, Spain.
Email: [email protected]
Search for more papers by this authorRicardo Ruiz-Villaverde
Department of Dermatology, University Hospital San Cecilio, Instituto Biosanitario de Granada, Ibs, Granada, Spain
Search for more papers by this authorSusana Armesto
Department of Dermatology, Marqués de Valdecilla University Hospital, Santander, Spain
Search for more papers by this authorJosep Manel Fernández-Armenteros
Department of Dermatology, Hospital de Viladecans, Barcelona, Spain
Department of Dermatology, Hospital Universitari Arnau de Vilanova, Lleida, Spain
Search for more papers by this authorJosep Riera-Monroig
Department of Dermatology, Hospital Clínic de Barcelona, Barcelona, Spain
Search for more papers by this authorTamara Gracia-Cazaña
Department of Dermatology, Hospital Miguel Servet, Zaragoza, Spain
Search for more papers by this authorMònica Quintana-Codina
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Search for more papers by this authorMaribel Iglesias-Sancho
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Search for more papers by this authorMontserrat Salleras
Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain
Search for more papers by this authorAdrián Imbernón Moya
Department of Dermatology, Hospital Universitario Severo Ochoa, Madrid, Spain
Search for more papers by this authorFrancisco Javier Melgosa Ramos
Department of Dermatology, Hospital Lluís Alcanyís de Xàtiva, Xàtiva, Spain
Search for more papers by this authorMarta Ferran
Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
Search for more papers by this authorOpen Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1Merola JF, Li T, Li WQ, Cho E, Qureshi AA. Prevalence of psoriasis phenotypes among men and women in the USA. Clin Exp Dermatol. 2016; 41(5): 486–489.
- 2Hong JJ, Mosca ML, Hadeler EK, Brownstone ND, Bhutani T, Liao WJ. Genital and inverse/intertriginous psoriasis: an updated review of therapies and recommendations for practical management. Dermatol Ther. 2021; 11(3): 833–844.
- 3Göblös A, Varga E, Farkas K, Árvai K, Kemény L. Genetic investigation of inverse psoriasis. Life. 2021; 11(7): 654.
- 4Ješe R, Perdan-Pirkmajer K, Dolenc-Voljč M, Tomšič M. A case of inverse psoriasis successfully treated with adalimumab. Acta Dermatovenerol Alp Panonica Adriat. 2014; 23(1): 21–23.
- 5Campos MA, Varela P, Baptista A, Moreira AI. Inverse psoriasis treated with ustekinumab. BMJ Case Rep. 2016; 2016:bcr2016215019.
- 6Xia RY, Liu J, Chen DD, Diao ZY, Gao YM, Yin ZQ. Ixekizumab for the treatment of Acrodermatitis continua of Hallopeau and inverse psoriasis. Indian J Dermatol. 2023; 68(2): 234.
- 7Lebwohl MG, Kircik LH, Moore AY, Stein Gold L, Draelos ZD, Gooderham MJ, et al. Effect of Roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials. JAMA. 2022; 328(11): 1073–1084.
- 8Xing X, Liang Y, Sarkar MK, Wolterink L, Swindell WR, Voorhees JJ, et al. IL-17 responses are the dominant inflammatory signal linking inverse, erythrodermic, and chronic plaque psoriasis. J Invest Dermatol. 2016; 136(12): 2498–2501.
- 9de Jesús-Gil C, Sans-de San Nicolàs L, Ruiz-Romeu E, Ferran M, Soria-Martínez L, García-Jiménez I, et al. Interplay between humoral and CLA+ T cell response against Candida albicans in psoriasis. Int J Mol Sci. 2021; 22(4): 1519–2501.
- 10Prussick L, Noelle C, Her M, Alomran A, Abudu M, Rosmarin D. Two cases of anti-interleukin-17 flared psoriasis. J Am Acad Dermatol. 2018; 79(3 Suppl 1):AB305.
